Struthers Richard Scott
Director, President & CEO · 5 filings · Latest: Sep 1, 2026
Crinetics Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRNX | Struthers Richard Scott | Director, President & CEO | Aug 7, 2026 | Option Exercise | $20.07 | 19,928 | $400.0K | 424,706 | |
CRNX | Struthers Richard Scott | Director, President & CEO | Mar 16, 2026 | Sale | $37.37 | 21,981 | $821.5K | 404,778 | |
CRNX | Richard Scott Struthers | — | Mar 16, 2026 | Proposed Sale | $37.49 | 45,013 | $1.7M | — | |
CRNX | Struthers Richard Scott | — | Sep 26, 2025 | Proposed Sale | $45.00 | 4,000 | $180.0K | — | |
CRNX | Struthers Richard Scott | — | Dec 2, 2024 | Proposed Sale | $57.27 | 10,000 | $572.7K | — |